Dr. Farid Brad Mozaffari, MD

Dr. Mozaffari practices at Scripps Memorial Hospital La Jolla in La Jolla, California, part of Scripps Health.

Dr. Mozaffari's NPI, 1639290075, was assigned on April 3, 2007. Dr. Mozaffari graduated from Kigezi International School of Medicine in 2000. Dr. Mozaffari's California license number on file is C156516.

Dr. Mozaffari's primary practice is Scripps Memorial Hospital La Jolla, at 9888 Genesee Avenue, La Jolla, CA 92037 in San Diego County. The practice phone is (858) 626-4123.

Dr. Mozaffari's primary practice is Scripps Memorial Hospital La Jolla in La Jolla, California, part of Scripps Health. Dr. Mozaffari is also affiliated with Charleston Area Medical Center General Hospital. The medical group on file is Charleston Area Medical Center. Dmand AI also links Dr. Mozaffari to 2 more group practices and clinics, 2 medical groups and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mozaffari practices, 5 sites in all. Vendor and product names are available with a free account.

Plastic surgery is Dr. Mozaffari's primary specialty in the NPI Registry, under taxonomy code 208200000X. Dr. Mozaffari is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. Mozaffari's licenses on file in 8 states: California, Florida, West Virginia, Kentucky, Arizona, Colorado, Georgia and Washington.

CMS data shows 14 Medicare services from Dr. Mozaffari across 1 procedure code in 2024, for 14 Medicare patients. Medicare paid $1,965 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 14 Medicare patients who saw Dr. Mozaffari in 2024. The largest group is under 65, with 0 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mozaffari's median patient age at 54, with 63% women.

In 2024, Dr. Mozaffari wrote 110 Medicare Part D claims for 23 patients. 97% of them were for generic drugs. CMS names the drug for 35 of them, across 3 drugs with 11 or more claims each, at $238 in total drug cost. In 2023, CMS named 85 claims across 6 drugs.

Dr. Mozaffari accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Mozaffari in 2018. Dr. Mozaffari's most frequent co-authors are Todd W. Gress, MD, David A. Denning, MD and Peter Damian Ray, MD.

CMS Open Payments shows 280 general payments to Dr. Mozaffari from 30 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 30% of the total. Lifecell Corporation paid the most, $26,627. It also lists 1 research payment totaling $500 in 2022.

Dmand AI lists 2 awards for Dr. Mozaffari, most recently ACS Fellow in 2013.

Dr. Mozaffari graduated from Kigezi International School of Medicine in 2000. Dr. Mozaffari is a member of ACS and ASPS.

Dr. Mozaffari is in network with 3 carriers, including Highmark, CMS Medicare and WV State Medicaid. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.